Onyekachi Ifudu

1.9k total citations
50 papers, 1.4k citations indexed

About

Onyekachi Ifudu is a scholar working on Nephrology, Hematology and Genetics. According to data from OpenAlex, Onyekachi Ifudu has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Nephrology, 19 papers in Hematology and 12 papers in Genetics. Recurrent topics in Onyekachi Ifudu's work include Dialysis and Renal Disease Management (28 papers), Erythropoietin and Anemia Treatment (17 papers) and Hemoglobinopathies and Related Disorders (12 papers). Onyekachi Ifudu is often cited by papers focused on Dialysis and Renal Disease Management (28 papers), Erythropoietin and Anemia Treatment (17 papers) and Hemoglobinopathies and Related Disorders (12 papers). Onyekachi Ifudu collaborates with scholars based in United States. Onyekachi Ifudu's co-authors include Eli A. Friedman, Peter Homel, Joseph Feldman, Morrell M. Avram, Jaime Uribarri, Keith Chirgwin, Eli A. Friedman, Mariana Markell, Barbara G. Delano and Adebayo Adewale and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Onyekachi Ifudu

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Onyekachi Ifudu United States 20 932 354 253 174 162 50 1.4k
Diane L. Frankenfield United States 25 1.1k 1.2× 306 0.9× 555 2.2× 248 1.4× 184 1.1× 78 1.8k
Steven Soroka Canada 17 858 0.9× 310 0.9× 140 0.6× 110 0.6× 85 0.5× 50 1.4k
Eduardo Lacson United States 23 1.4k 1.5× 233 0.7× 434 1.7× 240 1.4× 280 1.7× 40 1.9k
Erik Roys United States 12 690 0.7× 138 0.4× 294 1.2× 275 1.6× 378 2.3× 16 1.4k
Melissa Soohoo United States 28 1.1k 1.1× 132 0.4× 194 0.8× 274 1.6× 312 1.9× 74 1.8k
N Edward United Kingdom 17 605 0.6× 103 0.3× 85 0.3× 128 0.7× 197 1.2× 57 1.1k
Alice Martin United States 10 1.0k 1.1× 111 0.3× 316 1.2× 310 1.8× 288 1.8× 15 1.5k
Rachel B. Fissell United States 16 853 0.9× 102 0.3× 280 1.1× 267 1.5× 175 1.1× 31 1.7k
Jeannette G. van Manen Netherlands 16 1.7k 1.9× 173 0.5× 477 1.9× 227 1.3× 400 2.5× 19 2.0k
Asghar Rastegar United States 18 341 0.4× 214 0.6× 129 0.5× 222 1.3× 148 0.9× 41 1.1k

Countries citing papers authored by Onyekachi Ifudu

Since Specialization
Citations

This map shows the geographic impact of Onyekachi Ifudu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Onyekachi Ifudu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Onyekachi Ifudu more than expected).

Fields of papers citing papers by Onyekachi Ifudu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Onyekachi Ifudu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Onyekachi Ifudu. The network helps show where Onyekachi Ifudu may publish in the future.

Co-authorship network of co-authors of Onyekachi Ifudu

This figure shows the co-authorship network connecting the top 25 collaborators of Onyekachi Ifudu. A scholar is included among the top collaborators of Onyekachi Ifudu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Onyekachi Ifudu. Onyekachi Ifudu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ifudu, Onyekachi & Eli A. Friedman. (2009). Kidney injury, electrolyte and acid‐base abnormalities associated with use of alternative medicine products. Dialysis & Transplantation. 38(4). 124–127. 2 indexed citations
2.
Ifudu, Onyekachi, et al.. (2002). Relation between Interdialytic Weight Gain, Body Weight and Nutrition in Hemodialysis Patients. American Journal of Nephrology. 22(4). 363–368. 36 indexed citations
3.
Ifudu, Onyekachi, et al.. (2001). Gender modulates responsiveness to recombinant erythropoietin. American Journal of Kidney Diseases. 38(3). 518–522. 54 indexed citations
4.
Ifudu, Onyekachi. (2001). Maximizing response to erythropoietin in treating HIV-associated anemia.. Cleveland Clinic Journal of Medicine. 68(7). 643–648. 7 indexed citations
5.
Ifudu, Onyekachi, et al.. (2000). Adequacy of dialysis and differences in hematocrit among dialysis facilities. American Journal of Kidney Diseases. 36(6). 1166–1174. 21 indexed citations
6.
Ifudu, Onyekachi. (1999). Benefits of Combination Antihypertensive Therapy in Progressive Chronic Renal Failure. The American Journal of Managed Care. 5. 1 indexed citations
7.
Ifudu, Onyekachi. (1999). Optimal Use of Epoetin-?? in the Anaemia of Chronic Renal Failure. BioDrugs. 11(3). 175–183. 1 indexed citations
8.
Ifudu, Onyekachi & Eli A. Friedman. (1998). Effect of Increased Hemodialysis Dose on Endogenous Erythropoietin Production in End-Stage Renal Disease. ˜The œNephron journals/Nephron journals. 79(1). 50–54. 11 indexed citations
9.
Ifudu, Onyekachi, et al.. (1998). Predictive Value of Functional Status for Mortality in Patients on Maintenance Hemodialysis. American Journal of Nephrology. 18(2). 109–116. 96 indexed citations
10.
Ifudu, Onyekachi, et al.. (1998). Timing of Initiation of Uremia Therapy and Survival in Patients with Progressive Renal Disease. American Journal of Nephrology. 18(3). 193–198. 14 indexed citations
11.
Ifudu, Onyekachi. (1998). Parenteral Iron: Pharmacology and Clinical Use. ˜The œNephron journals/Nephron journals. 80(3). 249–256. 10 indexed citations
12.
Ifudu, Onyekachi, et al.. (1998). Initiation of Dialysis Is Not Delayed in Whites With Progressive Renal Failure. ASAIO Journal. 44(5). M598–M600. 4 indexed citations
13.
Ifudu, Onyekachi, Peter Homel, Joon H. Hong, et al.. (1997). Determinants of Type of Initial Hemodialysis Vascular Access. American Journal of Nephrology. 17(5). 425–427. 24 indexed citations
14.
Ifudu, Onyekachi, et al.. (1997). Severity of AIDS and the response to EPO in uremia. American Journal of Kidney Diseases. 30(1). 28–35. 14 indexed citations
15.
Ifudu, Onyekachi, et al.. (1996). Hemodialysis Immediately after Acute Myocardial Infarction. Nephron. 74(1). 104–109. 3 indexed citations
16.
Ifudu, Onyekachi, Joseph Feldman, & Eli A. Friedman. (1996). The Intensity of Hemodialysis and the Response to Erythropoietin in Patients with End-Stage Renal Disease. New England Journal of Medicine. 334(7). 420–425. 185 indexed citations
17.
Ifudu, Onyekachi, et al.. (1996). Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. American Journal of Kidney Diseases. 28(6). 841–845. 145 indexed citations
18.
Ifudu, Onyekachi, et al.. (1995). Zidovudine Is Beneficial in Human Immunodeficiency Virus Associated Nephropathy. American Journal of Nephrology. 15(3). 217–221. 67 indexed citations
19.
Ifudu, Onyekachi & Vera Delaney. (1994). Malacoplakia of the Prostate in a Renal Transplant Recipient. ASAIO Journal. 40(2). 238–240. 2 indexed citations
20.
Markell, Mariana, Bella T. Altura, Barbara G. Delano, et al.. (1993). Deficiency of Serum Ionized Magnesium in Patients Receiving Hemodialysis or Peritoneal Dialysis. ASAIO Journal. 39(3). M801–M804. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026